The development of mucosal vaccinations for oral transmucosal delivery using nanofabrication processes
It is estimated that by 2050, globally 10 million people will die due to antimicrobial resistance (AMR) related illness. Therefore, taking the world back to the pre-antibiotic era, where millions of people died from infectious diseases. Vaccines as tools to reduce AMR have historically been under-re...
| Κύριος συγγραφέας: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Thesis |
| Γλώσσα: | English |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | http://hdl.handle.net/10889/13597 |
